REPORT ID 6647

Asia-Pacific Opioid Antagonist Drug Market Report 2017

Publish Date
26-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the Asia-Pacific Opioid Antagonist Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Opioid Antagonist Drug for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Opioid Antagonist Drug market competition by top manufacturers/players, with Opioid Antagonist Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Conatus Pharmaceuticals
    Novartis
    Intercept Pharmaceuticals
    Allergan
    Immuron
    Takeda
    Gilead Sciences
    Genfit

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Tablet
    Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Opioid Antagonist Drug Market Report 2017
1 Opioid Antagonist Drug Overview
    1.1 Product Overview and Scope of Opioid Antagonist Drug
    1.2 Classification of Opioid Antagonist Drug by Product Category
        1.2.1 Asia-Pacific Opioid Antagonist Drug Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Opioid Antagonist Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Tablet
        1.2.4 Injection
    1.3 Asia-Pacific Opioid Antagonist Drug Market by Application/End Users
        1.3.1 Asia-Pacific Opioid Antagonist Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospital
        1.3.3 Medical Center
    1.4 Asia-Pacific Opioid Antagonist Drug Market by Region
        1.4.1 Asia-Pacific Opioid Antagonist Drug Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Opioid Antagonist Drug (2012-2022)
        1.5.1 Asia-Pacific Opioid Antagonist Drug Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Opioid Antagonist Drug Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Opioid Antagonist Drug Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Opioid Antagonist Drug Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Opioid Antagonist Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Opioid Antagonist Drug Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Opioid Antagonist Drug (Volume and Value) by Type
        2.2.1 Asia-Pacific Opioid Antagonist Drug Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Opioid Antagonist Drug Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Opioid Antagonist Drug (Volume) by Application
    2.4 Asia-Pacific Opioid Antagonist Drug (Volume and Value) by Region
        2.4.1 Asia-Pacific Opioid Antagonist Drug Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Opioid Antagonist Drug Revenue and Market Share by Region (2012-2017)

3 China Opioid Antagonist Drug (Volume, Value and Sales Price)
    3.1 China Opioid Antagonist Drug Sales and Value (2012-2017)
        3.1.1 China Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
        3.1.3 China Opioid Antagonist Drug Sales Price Trend (2012-2017)
    3.2 China Opioid Antagonist Drug Sales Volume and Market Share by Type
    3.3 China Opioid Antagonist Drug Sales Volume and Market Share by Application

4 Japan Opioid Antagonist Drug (Volume, Value and Sales Price)
    4.1 Japan Opioid Antagonist Drug Sales and Value (2012-2017)
        4.1.1 Japan Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Opioid Antagonist Drug Sales Price Trend (2012-2017)
    4.2 Japan Opioid Antagonist Drug Sales Volume and Market Share by Type
    4.3 Japan Opioid Antagonist Drug Sales Volume and Market Share by Application

5 South Korea Opioid Antagonist Drug (Volume, Value and Sales Price)
    5.1 South Korea Opioid Antagonist Drug Sales and Value (2012-2017)
        5.1.1 South Korea Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Opioid Antagonist Drug Sales Price Trend (2012-2017)
    5.2 South Korea Opioid Antagonist Drug Sales Volume and Market Share by Type
    5.3 South Korea Opioid Antagonist Drug Sales Volume and Market Share by Application

6 Taiwan Opioid Antagonist Drug (Volume, Value and Sales Price)
    6.1 Taiwan Opioid Antagonist Drug Sales and Value (2012-2017)
        6.1.1 Taiwan Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Opioid Antagonist Drug Sales Price Trend (2012-2017)
    6.2 Taiwan Opioid Antagonist Drug Sales Volume and Market Share by Type
    6.3 Taiwan Opioid Antagonist Drug Sales Volume and Market Share by Application

7 India Opioid Antagonist Drug (Volume, Value and Sales Price)
    7.1 India Opioid Antagonist Drug Sales and Value (2012-2017)
        7.1.1 India Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
        7.1.3 India Opioid Antagonist Drug Sales Price Trend (2012-2017)
    7.2 India Opioid Antagonist Drug Sales Volume and Market Share by Type
    7.3 India Opioid Antagonist Drug Sales Volume and Market Share by Application

8 Southeast Asia Opioid Antagonist Drug (Volume, Value and Sales Price)
    8.1 Southeast Asia Opioid Antagonist Drug Sales and Value (2012-2017)
        8.1.1 Southeast Asia Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Opioid Antagonist Drug Sales Price Trend (2012-2017)
    8.2 Southeast Asia Opioid Antagonist Drug Sales Volume and Market Share by Type
    8.3 Southeast Asia Opioid Antagonist Drug Sales Volume and Market Share by Application

9 Australia Opioid Antagonist Drug (Volume, Value and Sales Price)
    9.1 Australia Opioid Antagonist Drug Sales and Value (2012-2017)
        9.1.1 Australia Opioid Antagonist Drug Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Opioid Antagonist Drug Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Opioid Antagonist Drug Sales Price Trend (2012-2017)
    9.2 Australia Opioid Antagonist Drug Sales Volume and Market Share by Type
    9.3 Australia Opioid Antagonist Drug Sales Volume and Market Share by Application

10 Asia-Pacific Opioid Antagonist Drug Players/Suppliers Profiles and Sales Data
    10.1 Pfizer
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Pfizer Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Conatus Pharmaceuticals
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Conatus Pharmaceuticals Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Novartis
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Novartis Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Intercept Pharmaceuticals
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Intercept Pharmaceuticals Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Allergan
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Allergan Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Immuron
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Immuron Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Takeda
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Takeda Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Gilead Sciences
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Gilead Sciences Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Genfit
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Opioid Antagonist Drug Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Genfit Opioid Antagonist Drug Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview

11 Opioid Antagonist Drug Manufacturing Cost Analysis
    11.1 Opioid Antagonist Drug Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Opioid Antagonist Drug

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Opioid Antagonist Drug Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Opioid Antagonist Drug Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Opioid Antagonist Drug Market Forecast (2017-2022)
    15.1 Asia-Pacific Opioid Antagonist Drug Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Opioid Antagonist Drug Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Opioid Antagonist Drug Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Opioid Antagonist Drug Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Opioid Antagonist Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Opioid Antagonist Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Opioid Antagonist Drug Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Opioid Antagonist Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Opioid Antagonist Drug Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Opioid Antagonist Drug Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Opioid Antagonist Drug Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Opioid Antagonist Drug Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Opioid Antagonist Drug Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer